N89.1
Moderate vaginal dysplasia
Clinical Classification Guidelines
Inclusion Terms
- Vaginal intraepithelial neoplasia [VAIN], grade II
Medical Intelligence & Overview
Moderate vaginal dysplasia, also known as Vaginal Intraepithelial Neoplasia (VAIN) grade II, is a condition characterized by abnormal changes in the cells lining the vagina. It is considered a precancerous stage, meaning it has the potential to develop into vaginal cancer if left untreated. Recognizing and managing VAIN early is essential for maintaining vaginal health and preventing progression to malignancy.
Causes & Symptoms
Clinical Causes: Persistent infection with high-risk human papillomavirus (HPV) types Immunosuppression, such as from HIV or immunosuppressive therapy History of cervical or other gynecological neoplasia Multiple sexual partners or early sexual activity Smoking, which may impair immune response History of vaginal or cervical intraepithelial neoplasia
Key Symptoms: Often asymptomatic, with no noticeable signs Vaginal bleeding or spotting, especially after intercourse Unusual vaginal discharge Soreness, itching, or irritation in the vaginal area If symptoms are present, they tend to be mild and nonspecific
Diagnostic & Treatment
Diagnosis Path: To diagnose moderate vaginal dysplasia, a healthcare provider may perform the following steps: - **Pelvic examination:** To visually inspect the vaginal walls for abnormal areas. - **Pap smear (Pap test):** To collect cells from the vaginal lining for cytology analysis. - **Vaginal biopsy:** Taking a small tissue sample from suspicious areas for microscopic examination, confirming the presence and grade of dysplasia. - **HPV testing:** To identify high-risk HPV strains associated with precancerous changes. - **Colposcopy:** Using a specialized magnifying device to examine the vaginal tissues more closely.
Treatment Protocols: Management of moderate vaginal dysplasia aims to remove abnormal cells and prevent progression to cancer. Treatment options may include: - **Observation:** In some cases, especially if the dysplasia is limited and not causing symptoms, careful follow-up with regular examinations may be recommended. - **Topical medications:** Such as imiquimod cream to stimulate immune response and clear abnormal cells. - **Local excision procedures:** Including laser therapy, or excisional surgeries like loop electrosurgical excision procedure (LEEP), to remove affected tissue. - **Cryotherapy:** Freezing abnormal tissues to destroy dysplastic cells. - **Follow-up evaluations:** Regular monitoring post-treatment to detect any recurrence or progression.
Clinical Advice & FAQs
Billing Guidance
Is N89.1 a billable ICD-10 code?
Yes, N89.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N89.1?
Clinical documentation must specify the nature of Moderate vaginal dysplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
